ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,421.03
0.85%
US Tech 100
19,066.40
0.53%
Dow Jones
38,712.21
-0.09%
Brent Oil
81.665
-0.77%
Bitcoin
67,368.23
-1.29%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Synergy Pharmaceuticals, Inc. (MM) (SGYPD)

  7. Synergy Pharmaceuticals, Inc. (MM) (SGYPD) News

SGYPD

Synergy Pharmaceuticals, Inc. (MM) (SGYPD)

Synergy Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SGYPD
DateTimeSourceHeadlineSymbolCompany
03/01/20197:13PMDow Jones NewsSynergy Pharmaceuticals Is Approved to Sell Assets to Bausch HealthNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
02/26/20197:07PMDow Jones NewsBausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/17/20183:43PMDow Jones NewsSynergy Pharmaceuticals Up 55% on Trulance Progress in CanadaNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/12/201811:10AMDow Jones NewsFormer Pharma Highflier Appreciates Bathroom Humor -- OverheardNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/12/20188:18AMDow Jones NewsBausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--UpdateNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/12/20187:14AMDow Jones NewsBausch Health Agrees to Buy Synergy Pharmaceuticals for $200 MillionNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
01/03/20124:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
01/03/20124:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
01/03/20124:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/27/20114:05PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/22/20116:01AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/21/201112:18PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/19/20115:04PMEdgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/16/20112:35PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/13/20114:41PMBusiness WireSynergy Pharmaceuticals Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/13/201111:56AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/13/20118:00AMPR Newswire (US)Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior V...NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/13/20113:00AMBusiness WireSynergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. & its Chief Scientific Officer & Senior VP of...NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/08/20114:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/08/20114:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/08/20114:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/08/20114:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/08/20114:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/07/201110:31AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/06/20115:00PMBusiness WireSynergy Pharmaceuticals Announces Closing of Public Offering of 1,875,000 UnitsNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/01/20115:17PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/01/20115:14PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(2) (424B2)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/01/20118:00AMBusiness WireSynergy Pharmaceuticals Inc. Announces Pricing of Public Offering of 1,875,000 Units, Listing on NASDAQ & Effectiveness of Re...NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:SGYPD

Your Recent History

USOTC
VXIT
Virexit Technologies (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
MCIC
Multicorp (PK)
USOTC
PPCB
Propanc Biopharma (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
SFLM
SFLMaven (PK)
NASDAQ
AGBA
AGBA
USOTC
FMCC
Federal Home Loan Mortgage (QB)
USOTC
ASRE
Astra Energy (QB)
USOTC
SAPX
Seven Arts Entertainment (PK)
NASDAQ
JAGX
Jaguar Health
USOTC
IFUS
Impact Fusion (PK)
USOTC
PHIL
PHI (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
RONN
Ronn Motor (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved